Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases

Isr Med Assoc J. 2008 Aug-Sep;10(8-9):634-9.

Authors

Yoram Bujanover¹, Batia Weiss

Affiliation

¹ Division of Pediatric Gastroenterology and Nutrition, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel. bujyoram@netvison.net.il

PMID: 18847168

No abstract available

Publication types

Review

MeSH terms

Anti-Inflammatory Agents / adverse effects
Anti-Inflammatory Agents / therapeutic use*
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use*
Antibody Formation
Child
Humans
Inflammatory Bowel Diseases / drug therapy*
Infliximab
Tumor Necrosis Factor-alpha / immunology*

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha
Infliximab